{ "cik": 1668243, "cik_padded": "0001668243", "entityName": "UroGen Pharma Ltd.", "fiscal_years": [ { "accn": "0001437749-26-006234", "filed": "2026-03-02", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 289000.0, "cash": 110745000.0, "cost_of_revenue": 12447000.0, "free_cash_flow": -162733000.0, "gross_profit": 97341000.0, "net_income": -153494000.0, "operating_cash_flow": -162444000.0, "operating_income": -124863000.0, "revenue": 109788000.0, "stockholders_equity": -105474000.0, "total_assets": 200455000.0, "total_liabilities": 305929000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.8866269537654389, "net_margin": -1.3980945094181514, "operating_margin": -1.137310088534266, "revenue_growth_yoy": 0.21449589592690105, "roa_avg2y": -0.6314468720560467, "roa_period_end": -0.7657279688708187, "roe_avg2y": 2.6863498341748557 } }, { "accn": "0001437749-26-006234", "filed": "2026-03-02", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 295000.0, "cash": 171987000.0, "cost_of_revenue": 8881000.0, "free_cash_flow": -97061000.0, "gross_profit": 81517000.0, "net_income": -126874000.0, "operating_cash_flow": -96766000.0, "operating_income": -96782000.0, "revenue": 90398000.0, "stockholders_equity": -8803000.0, "total_assets": 285711000.0, "total_liabilities": 294514000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.9017566760326556, "net_margin": -1.403504502311998, "operating_margin": -1.0706210314387485, "revenue_growth_yoy": 0.09291163420502219, "roa_avg2y": -0.5468447616707829, "roa_period_end": -0.44406410673722746, "roe_avg2y": 3.4283320948456395 } }, { "accn": "0001437749-26-006234", "filed": "2026-03-02", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 194000.0, "cash": 95002000.0, "cost_of_revenue": 9361000.0, "free_cash_flow": -76570000.0, "gross_profit": 73352000.0, "net_income": -102244000.0, "operating_cash_flow": -76376000.0, "operating_income": -65536000.0, "revenue": 82713000.0, "stockholders_equity": -65212000.0, "total_assets": 178311000.0, "total_liabilities": 243523000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.8868255292396601, "net_margin": -1.2361297498579424, "operating_margin": -0.7923301053038821, "revenue_growth_yoy": 0.28522149882685643, "roa_avg2y": -0.6513808810881406, "roa_period_end": -0.5734026504253804, "roe_avg2y": 1.3229218556927795 } }, { "accn": "0001437749-25-006842", "filed": "2025-03-10", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 254000.0, "cash": 55408000.0, "cost_of_revenue": 7654000.0, "free_cash_flow": -87813000.0, "gross_profit": 56703000.0, "net_income": -109783000.0, "operating_cash_flow": -87559000.0, "operating_income": -79041000.0, "revenue": 64357000.0, "stockholders_equity": -89361000.0, "total_assets": 135619000.0, "total_liabilities": 224980000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.881069658312227, "operating_margin": -1.2281647684012618, "revenue_growth_yoy": 0.3395986844844095, "roa_avg2y": -0.8598124253519472, "roa_period_end": -0.809495719626306, "roe_avg2y": 2.712432672827 } }, { "accn": "0001437749-24-007753", "filed": "2024-03-14", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 752000.0, "cash": 44360000.0, "cost_of_revenue": 5157000.0, "free_cash_flow": -85644000.0, "gross_profit": 42885000.0, "net_income": -110820000.0, "operating_cash_flow": -84892000.0, "operating_income": -92292000.0, "revenue": 48042000.0, "stockholders_equity": 8413000.0, "total_assets": 119746000.0, "total_liabilities": 111333000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.8926564256275759, "revenue_growth_yoy": 3.0717009916094584, "roa_avg2y": -0.9168110990233753, "roa_period_end": -0.9254588879795569, "roe_avg2y": -2.1155314599877824 } }, { "accn": "0001437749-23-007710", "filed": "2023-03-24", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1215000.0, "cash": 52864000.0, "cost_of_revenue": 1009000.0, "free_cash_flow": -107101000.0, "gross_profit": 10790000.0, "net_income": -128484000.0, "operating_cash_flow": -105886000.0, "operating_income": -126739000.0, "revenue": 11799000.0, "stockholders_equity": 96355000.0, "total_assets": 122005000.0, "total_liabilities": 25650000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.914484278328672, "revenue_growth_yoy": 654.5, "roa_avg2y": -0.7921502621819829, "roa_period_end": -1.0531043809679932, "roe_avg2y": -0.9288324531820992 } }, { "accn": "0001437749-22-006778", "filed": "2022-03-21", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 325000.0, "cash": 49688000.0, "cost_of_revenue": 0.0, "free_cash_flow": -71342000.0, "gross_profit": 18000.0, "net_income": -105146000.0, "operating_cash_flow": -71017000.0, "operating_income": -109478000.0, "revenue": 18000.0, "stockholders_equity": 180302000.0, "total_assets": 202388000.0, "total_liabilities": 22086000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 1.0, "revenue_growth_yoy": -0.9840425531914894, "roa_avg2y": -0.6873478086073732, "roa_period_end": -0.5195268494179497, "roe_avg2y": -0.7777186053048122 } }, { "accn": "0001564590-21-014016", "filed": "2021-03-18", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 560000.0, "cash": 101318000.0, "cost_of_revenue": 1803000.0, "free_cash_flow": -37894000.0, "gross_profit": -675000.0, "net_income": -75657000.0, "operating_cash_flow": -37334000.0, "operating_income": -77180000.0, "revenue": 1128000.0, "stockholders_equity": 90094000.0, "total_assets": 103559000.0, "total_liabilities": 13465000.0 }, "period_end": "2018-12-31", "ratio_units": { "gross_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": -0.598404255319149, "revenue_growth_yoy": -0.8617308163765629, "roa_avg2y": -0.8448151684169974, "roa_period_end": -0.7305690475960563, "roe_avg2y": -0.9540063930798378 } }, { "accn": "0001564590-20-007970", "filed": "2020-03-02", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 271000.0, "cash": 36999000.0, "cost_of_revenue": 600000.0, "free_cash_flow": -9839000.0, "gross_profit": 7558000.0, "net_income": -20000000.0, "operating_cash_flow": -9568000.0, "operating_income": -19950000.0, "revenue": 8158000.0, "stockholders_equity": 68515000.0, "total_assets": 75550000.0, "total_liabilities": 7035000.0 }, "period_end": "2017-12-31", "ratio_units": { "gross_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.9264525619024271, "roa_avg2y": -0.40565482830659394, "roa_period_end": -0.26472534745201853, "roe_avg2y": -0.47157577043691495 } }, { "accn": "0001564590-20-007970", "filed": "2020-03-02", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 695000.0, "cash": 21362000.0, "free_cash_flow": 3494000.0, "gross_profit": 17502000.0, "net_income": -1941000.0, "operating_cash_flow": 4189000.0, "operating_income": 798000.0, "stockholders_equity": 16307000.0, "total_assets": 23056000.0, "total_liabilities": 6749000.0 }, "period_end": "2016-12-31", "ratio_units": { "roa_period_end": "ratio" }, "ratios": { "roa_period_end": -0.08418632893823734 } } ], "latest_filing": { "accn": "0001437749-26-006234", "filed": "2026-03-02", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001668243.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001668243.json" }, "ticker": "URGN" }